Inhibition of plasminogen activator inhibitor-1 by angiotensin II receptor blockers on cyclosporine-treated renal allograft recipients

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 994-996

  Ishikawa, A ^a,b   Ohta, N ^b   Ozono, S ^c   Kawabe, K ^b   Kitamura, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Yaizu Municipal General Hospital   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN HEXETIL; CYCLOSPORIN A; LOSARTAN; NIFEDIPINE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MEGADOSE; FEMALE; HUMAN; HYPERTENSION; INFORMED CONSENT; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RECIPIENT;

EID: 17844400078     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.226     Document Type: Conference Paper

References (14)

1. A. Ishikawa, K. Kawabe Beneficial effect of losartan against proteinuria from the renal allograft Transplant Proc 35 2003 289
2. K. Takeshita, M. Hayashi, S. Iino Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction Am J Pathol 164 2004 449
3. N.J. Brown, D.E. Vaughan, A.B. Fogo The renin-angiotensin-aldosterone system and Fibrinolysis in progressive renal disease Semin Nephrol 22 2002 399
4. G. Grandaliano, S. Di Paolo, R. Monno Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and Fibrinolysis in renal graft fibrosis Transplantation 72 2001 1473
5. T. Oda, Y.O. Jung, H.S. Kim PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction Kidney Int 60 2001 587
6. L. Gesualdo, E. Ranieri, R. Monno Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial calls Kidney Int 56 1999 461
7. A. Vianello, S. Mastrosimone, G. Calconi The role of hypertension as a damaging factor for kidney grafts under cyclosporine therapy Am J Kidney Dis 21 1993 79
8. EBPG Expert Group on Renal Transplantation European best practice guidelines for renal transplantation Section IV: Long-term management of the transplant recipient. IV 5.2. Cardiovascular risks. Arterial hypertension Nephrol Dial Transplant 17 suppl 4 2002 25
9. J.M. Campistol, R. Romero, J. Paul Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade Nephrol Dial Transpl 19 suppl 3 2004 62
10. K.C. Mange, B. Cizman, M. Joffe Arterial hypertension and renal allograft survival JAMA 283 2000 633
11. J.L. Mehta, D.Y. Li, H. Yang Angiotensin II and IV stimulate expression and release of plasminogen activator inhibitor-1 in cultured human coronary artery endothelial cells J Cardiovasc Pharmacol 39 2002 789
12. T. Skurk, Y.M. Lee, H. Hauner Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture Hypertension 37 2001 1336
13. G. Remuzzi, N. Perico Routine renin-angiotensin system blockade in renal transplantation? Curr Opin Nephrol Hypertens 11 2002 1
14. R. Holgado, F. Anaya, D. Del Castillo Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation Nephrol Dial Transplant 16 suppl 1 2001 117